|
|
|
|
|
|
|
Poster: 226
Visits: 121
Title: Addition of Rituximab to the Treatment of Newly Diagnosed Primary CNS Lymphoma is Associated with Improved Outcome: A French LOC Network study
Authors: Emmanuel Gyan ,
Centre: CHU de Tours
|
|
You must be registered to reply or comment.
|
|
ADDITION OF RITUXIMAB TO THE TREATMENT OF NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA IS ASSOCIATED WITH IMPROVED OUTCOME: A FRENCH LOC NETWORK STUDY
|
|
You must be registered to reply or comment. |
|
|
|
|
|
|
Most viewed poster for this congress |
|
|
Poster: 9
Visits: 649
Title: Ibrutinib in combination with Rituximab for Relapsed Mantle Cell Lymphoma: An Update from a Phase II Clinical Trial
Authors: Michael Wang ,
Centre: The University of Texas MD Anderson Cancer Center
|
|
|
|
|
|
|
Poster most viewed in this topic |
|
|
Poster: 154
Visits: 188
Title: NR4A3 suppresses lymphomagenesis by induction of apoptosis and serves as a drug target for lymphoma therapy
Authors: Alexander Deutsch ,
Centre: Clinical Devision of Hematology
|
|
|
|